Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Addiction. 2019 Jun 24;114(9):1593–1601. doi: 10.1111/add.14661

Table 2.

Association between medical marijuana laws (MML) and substance use treatment admissions by nonpregnant women per 100,000 women

Marijuana Alcohol Rx Opioids Heroin Cocaine
MML 24.62 11.6 21.91 −9.04 −16.49
[−10.33, 59.58] [−42.17, 65.38] [−16.09, 59.91] [−65.04, 46.95] [−55.16, 22.18]
Mean 308.03 498.28 170.66 269.11 288.5
N 606 606 606 606 606

Source: Treatment Episode Data Set Admissions, 2002–2014.

Notes: Coefficients are based on a difference-in-differences approach that estimates changes in outcomes and accounts for controls. Controls include state unemployment rates, beer excise tax rates, Medicaid income eligibility thresholds for pregnant women, the Affordable Care Act Medicaid expansions, pain clinic laws, prescription drug monitoring program operations and mandates, and recreational marijuana laws. State-year treatment admission counts of nonpregnant women ages 12 to 49 are divided by state population estimates of women ages 12 to 49 and multiplied by 100,000. The mean captures average outcomes 2 years prior to MML implementation for MML states. Confidence intervals are in parentheses.

***

p<0.01,

**

p<0.05,

*

p<0.1